Modeling polygenic embryo screening in real-world IVF patients demonstrates limitations on efficacy
Liraz Klausner, Elvezia Maria Paraboschi, Francesca Mulas, Ludovica Picchetta, Christian Simon Ottolini, Ateret Revital, Danilo Cimadomo, Alberto Vaiarelli, Todd Lencz, Antonio Capalbo, Shai Carmi
This paper models polygenic embryo screening (PES) in IVF patients and finds it leads to small relative risk reductions in most cases due to low live birth rates and limited embryo availability.
medRxiv · Apr 20, 2026 · PreprintGenetic & Genomic Medicine